1. Home
  2. CCEL vs BCG Comparison

CCEL vs BCG Comparison

Compare CCEL & BCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCEL
  • BCG
  • Stock Information
  • Founded
  • CCEL 1989
  • BCG 2016
  • Country
  • CCEL United States
  • BCG United States
  • Employees
  • CCEL N/A
  • BCG N/A
  • Industry
  • CCEL Managed Health Care
  • BCG
  • Sector
  • CCEL Health Care
  • BCG
  • Exchange
  • CCEL Nasdaq
  • BCG Nasdaq
  • Market Cap
  • CCEL 39.9M
  • BCG 41.3M
  • IPO Year
  • CCEL 1997
  • BCG N/A
  • Fundamental
  • Price
  • CCEL $5.19
  • BCG $2.00
  • Analyst Decision
  • CCEL Strong Buy
  • BCG
  • Analyst Count
  • CCEL 1
  • BCG 0
  • Target Price
  • CCEL $8.50
  • BCG N/A
  • AVG Volume (30 Days)
  • CCEL 14.7K
  • BCG 10.7K
  • Earning Date
  • CCEL 07-14-2025
  • BCG 08-14-2025
  • Dividend Yield
  • CCEL 19.49%
  • BCG N/A
  • EPS Growth
  • CCEL N/A
  • BCG N/A
  • EPS
  • CCEL 0.01
  • BCG N/A
  • Revenue
  • CCEL $32,102,750.00
  • BCG $172,860,000.00
  • Revenue This Year
  • CCEL $2.49
  • BCG N/A
  • Revenue Next Year
  • CCEL $0.95
  • BCG N/A
  • P/E Ratio
  • CCEL $568.17
  • BCG N/A
  • Revenue Growth
  • CCEL 2.33
  • BCG 7.36
  • 52 Week Low
  • CCEL $4.75
  • BCG $1.71
  • 52 Week High
  • CCEL $9.43
  • BCG $6.55
  • Technical
  • Relative Strength Index (RSI)
  • CCEL 51.22
  • BCG N/A
  • Support Level
  • CCEL $5.00
  • BCG N/A
  • Resistance Level
  • CCEL $6.35
  • BCG N/A
  • Average True Range (ATR)
  • CCEL 0.31
  • BCG 0.00
  • MACD
  • CCEL 0.02
  • BCG 0.00
  • Stochastic Oscillator
  • CCEL 14.07
  • BCG 0.00

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

About BCG Binah Capital Group Inc. Common Stock

Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.

Share on Social Networks: